Skip to main content
Caplight Logo









Voro Therapeutics

Voro Therapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.vorotx.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Voro Therapeutics is a biotechnology company that develops a tumor-activated biologics platform, PrimeBody™, to enable safer and more effective cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

tumor-activated biologicsmasked antibodiesantibody-drug conjugatesADCsoncologyprodrug technologyconditionally activated biologicsoff-tumor toxicitytumor microenvironmentdrug development platformT-cell engagersprotease-cleavable linkerstherapeutic windowbiotech licensingCD47 blocker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Voro Therapeutics Comparables

Compare Voro Therapeutics with similar companies based on industry and business-model similarity.

Voro Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bonum Therapeutics
86%
CytomX Therapeutics
82%
Xilio Therapeutics
79%

Voro Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Ugur Eskiocak

CEO & Co-Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 99% MoM.

  • May 18, 2026

    Monthly visitors increased 54% MoM.

Voro Therapeutics Filings

Explore SEC and related filing metadata, where available.

Voro Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Voro Therapeutics's valuation, stock price, and market status.

Is Voro Therapeutics a public or private company?

Voro Therapeutics is a private company.

What is the current stock price of Voro Therapeutics?

Voro Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Voro Therapeutics worth (valuation)?

Valuation information for Voro Therapeutics is not publicly available.

Can I buy Voro Therapeutics stock?

Voro Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Voro Therapeutics's last funding round?

Funding round information for Voro Therapeutics is not publicly available.

Who are the main investors in Voro Therapeutics?

Investor information for Voro Therapeutics is not publicly disclosed.

Will Voro Therapeutics IPO soon?

No public IPO plans have been announced for Voro Therapeutics.

How can I track Voro Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Voro Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range11
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?